A comparison of dosing accuracy: Visually impaired and sighted people using insulin pens

Journal of Diabetes Science and Technology

Volumn 4, Issue 3, 2010, Pages 514-521

  Williams, Ann S ^a   Schnarrenberger, Patrick A ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Blindness; Disability; Dosing accuracy; Insulin pen; Universal design; Visual impairment

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; COMPARATIVE STUDY; DIABETES MELLITUS; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; PATIENT; SUBCUTANEOUS DRUG ADMINISTRATION;

DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; SELF ADMINISTRATION; VISUALLY IMPAIRED PERSONS;

EID: 78349284454     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400303     Document Type: Conference Paper

References (50)

1. Centers for Disease Control and Prevention. Diabetes Data and Trends. 2007 [cited 2009 Dec 11]. Available from: http://apps.nccd.cdc.gov/DDTSTRS/ default.aspx.
2. Williams AS. Accessible diabetes education materials in low-vision format. Diabetes Educ. 1999;25(5):695-8, 700, 702 passim.
3. Williams A. Diabetes and visual impairment - identifying needs, ensuring full accessibility. Diabetes Voice. 2008:9-12.
4. Bernbaum M, Albert SG, Brusca S, McGinnis J, Miller D, Hoffmann JW, Mooradian AD. Effectiveness of glucose monitoring systems modified for the visually impaired. Diabetes Care. 1993;16(10):1363-6. (Pubitemid 23289475)
5. Bernbaum M, Albert SG, Brusca SR, Drimmer A, Duckro PN, Cohen JD, Trindade MC, Silverberg AB. A model clinical program for patients with diabetes and vision impairment. Diabetes Educ. 1989;15(4):325-30.
6. Bernbaum M, Albert SG, Cohen JD, Drimmer A. Cardiovascular conditioning in individuals with diabetic retinopathy. Diabetes Care. 1989;12(10):740-2. (Pubitemid 19284098)
7. Williams AS. A focus group study of accessibility and related psychosocial issues in diabetes education for people with visual impairment. Diabetes Educ. 2002;28(6):999-1008.
8. Williams AS. Making diabetes education accessible for people with visual impairment. Diabetes Educ. 2009;35(4):612-21.
9. Sokol-McKay D, Buskirk K, Whittaker P. Adaptive low-vision and blindness techniques for blood glucose monitoring. Diabetes Educ. 2003;29(4):614-8, 620, 622 passim.
10. Bartos BJ, Cleary ME, Kleinbeck C, Petzinger RA, Sokol-McKay DA, Whittington A, Williams AS. Diabetes and disabilities: assistive tools, services, and information. Diabetes Educ. 2008;34(4):597-8, 600, 603-5 passim.
11. Kleinbeck C. Tools and techniques for visual impairment. Diabetes Self Manag. 2006;23(1):42, 44, 46, 48-51.
12. Cate Y, Baker SS, Gilbert MP. Occupational therapy and the person with diabetes and vision impairment. Am J Occup Ther. 1995;49(9):905-11.
13. Herget MJ, Williams AS. New aids for low-vision diabetics. Am J Nurs. 1989;89(10):1319-22.
14. Ponchillia SV. Diabetes management and visual impairment. J Visual Impairment Blindness. 2006;100(special supplement):867-71.
15. American Foundation for the Blind. Diabetes and vision loss: a guide to caring for yourself when you have vision loss. 2008 [cited 2008 Dec 12]. Available from: http://www.afb.org/seniorsite.asp?SectionID=63&TopicID=396.
16. National Federation of the Blind. NFB - voice of the diabetic. 2008 [cited 2008 Dec 12]. Available from: http://www.nfb.org/nfb/Voice-of-the- Diabetic.asp.
17. Jernigan K. A definition of blindness. Future reflections [serial on the Internet][cited 2008 Nov 5]. Available from: http://www.nfb.org/Images/nfb/ Publications/fr/fr19/fr05si03.htm.
18. Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, Vitali L, Bulotta A, Nicoziani P, Coronel G; QuoLITy Study Group. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009;19(1):45-53.
19. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care. 2004;27(10):2495-7. (Pubitemid 39281409)
20. Sommavilla B, Jorgensen C, Jensen K. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother. 2008;9(13):2223-32.
21. Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care. 2008;31(3):430-2.
22. .Klonoff DC. The pen is mightier than the needle (and syringe). Diabetes Technol Ther. 2001;3(4):631-3. (Pubitemid 34202922)
23. Spollett G. Addressing barriers to insulin therapy with the ideal pen. Diabetes Educ. 2008;34(6):957-67, 963, 967.
24. Ley T. Does anyone have a pen? Voice of the diabetic [serial on the Internet][cited 2008 Nov 3]. Available from: http://www.nfb.org/Images/nfb/ Publications/vod/vod215/vodwin0708.htm.
25. Sokol-McKay D. Sugar blues: insulin pens - what they are and how do they work. The RT News [serial on the Internet] [cited 2008 Nov 3]. Available from: http://www.rehabilitationteaching.org/rtnews032008.htm.
26. Clarke A, Dain MP. Dose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism. Expert Opin Drug Deliv. 2006;3(5):677-83. (Pubitemid 44389028)
27. Hermanns N, Kulzer B, Haak T. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting. Diabetes Technol Ther. 2008;10(4):322-7.
28. Schwartz S, Vlajnic A. Validation of the SoloSTAR insulin pen. Diabetes Technol Ther. 2008;10(5):351-7.
29. Pfutzner A, Asakura T, Sommavilla B, Lee W. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence. Expert Opin Drug Deliv. 2008;5(8):915-25.
30. Asakura T, Seino H, Kageyama M, Yohkoh N. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin. 2008;24(5):1429-34. (Pubitemid 351741576)
31. Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child. 1998;79(1):59-62. (Pubitemid 28331256)
32. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila). 2004;43(1):69-74. (Pubitemid 38112268)
33. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care. 1999;22(1):137-40. (Pubitemid 29028310)
34. Fox C, McKinnon C, Wall A, Lawton S. Ability to handle, and patient preference for, insulin delivery devices in visually impaired patients with type 2 diabetes. Practical Diabetes Int. 2002;19(4):104-7.
35. Haak T, Edelman S, Walter C, Lecointre B, Spollett G. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study. Clin Ther. 2007;29(4):650-60. (Pubitemid 47016637)
36. Asakura T, Seino H. Assessment of dose selection attributes with audible notification in insulin pen devices. Diabetes Technol Ther. 2005;7(4):620-6. (Pubitemid 41208625)
37. Uslan MM. Analysis: Beyond the "clicks" of dose setting in insulin pens. Diabetes Technol Ther. 2005;7(4):627-8. (Pubitemid 41208626)
38. Burton D, Uslan M. Diabetes and visual impairment: are insulin pens accessible? Access World [serial on the Internet][cited 2008 Nov 3]. Available from: http://www.afb.org/AFBPress/pub.asp?DocID= aw070403.
39. National Federation of the Blind. Resolution 2008-07: Regarding insulin pen disclaimer. Braille Monitor [serial on the Internet] [cited 2008 Nov 3]. Available from: http://www.nfb.org/images/nfb/Publications/bm/bm08/bm0808/ bm080812. htm.
40. Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry. 2005;62(7):726-33. (Pubitemid 41002753)
41. Williams A, Schnarrenberger P. Ensuring valid measurements for a disabled population: an insulin pen pilot study. J Diabetes Sci Technol. 2010;4(1):230.
42. Grissinger M, Lease M. Misadventures in insulin therapy: are you at risk? J Natl Med Assoc. 2003;95(2 Suppl 1):1S-16S. (Pubitemid 37099550)
43. Scott R. The making of blind men: a study of adult socialization. New York: Russell Sage Foundation; 1969.
44. Omvig J. Freedom for the blind: the secret is empowerment. Baltimore, MD: National Federation for the Blind; 2005.
45. Taylor D. A review of rehabilitation in America: reflections of the past, observations of the present, and speculations about the future. Braille Monitor; 2005.
46. Tuttle D, Tuttle N. Self-esteem and adjusting with blindness: the process of responding to life's demands. 3rd ed. Springfield, IL: Charles C. Thomas Publishers; 2004.
47. Fiske S, Cuddy AC, Glick P, Xu J. A model of (often mixed) stereotype content: Competence and warmth respectively follow from perceived status and competition. J Pers Soc Psychol. 2002;82(6):878-902.
48. Shapiro J. No pity: people with disabilities forging a new civil rights movement. New York: Times Books; 1993.
49. Americans with Disabilities Act of 1990: Public Law 101-336; 1990.
50. Connell B, Jones M, Mace R, Mueller J, Mullick A, Ostroff E, Sanford J, Steinfeld E, Story M, Vanderheiden G. About UD: universal design principles. Center for Universal Design, North Carolina State University; 1997 [cited 2009 Apr 13]. Available from: http://www.design.ncsu.edu/cud/about-ud/ udprincipleshtmlformat.html#top.